Facial Upper Motor Neuron (UMN) vs Lower Motor Neuron (LMN) Lesions
Clinical Distinction: The Critical First Step
The key to distinguishing UMN from LMN facial lesions is forehead involvement: LMN lesions affect the entire hemiface including forehead, while UMN lesions spare the forehead due to bilateral cortical innervation of the upper facial muscles. 1
Examination Findings
LMN Pattern (Peripheral Facial Palsy):
- Complete hemifacial weakness including inability to wrinkle forehead, close eye, or smile on affected side 2
- Loss of nasolabial fold and drooping of mouth corner 2
- All facial muscles on one side are affected equally 1
UMN Pattern (Central Facial Palsy):
- Forehead movement preserved (can wrinkle forehead and close eyes) 1
- Lower face weakness only (difficulty smiling, showing teeth) 1
- Often accompanied by contralateral limb weakness suggesting stroke 1, 3
Critical Pitfall: Central Causes Can Present as LMN Pattern
A dorsal pontine lesion affecting the facial colliculus can produce an LMN facial palsy pattern despite being a central lesion. 3 This occurs because the lesion affects the facial nerve fascicles before they exit the brainstem. Associated findings include:
- Ipsilateral conjugate gaze palsy (abducens nerve involvement) 3
- Cerebellar signs (ataxia, nystagmus) 3
- Other cranial nerve palsies 3
Any LMN facial palsy with additional neurological signs warrants immediate brain imaging to exclude stroke or space-occupying lesions, even in young patients without vascular risk factors. 3
Diagnostic Approach
When to Image
For isolated LMN facial palsy (Bell's palsy), imaging is not routinely indicated unless: 2, 4
- Symptoms are atypical or recurrent 4
- No improvement after 2-4 months 4
- Other neurological signs are present 2, 3
- Progressive or complete paralysis from onset 5
For UMN facial palsy with limb weakness, immediate stroke protocol imaging (CT or MRI) is mandatory. 1
Imaging Protocol When Indicated
MRI is the preferred modality for evaluating facial nerve pathology: 2, 4
- Pre- and post-contrast sequences with sensitivity 73-100% for detecting lesions 4
- High-resolution thin-cut sequences through entire facial nerve course 4
- Coverage must include brainstem, cerebellopontine angle, temporal bone segments, and parotid gland 4
- 3D heavily T2-weighted sequences for vascular compression evaluation 4
High-resolution temporal bone CT provides complementary information for: 4
- Osseous integrity of facial nerve canal 4
- Trauma or suspected fractures 4
- Facial nerve canal dehiscence 1
Electrodiagnostic Testing
For Bell's palsy with incomplete paralysis, electrodiagnostic testing should not be performed. 2
For complete facial paralysis, electroneurography (ENoG) and electromyography (EMG) may be offered to guide surgical decisions: 2, 1
- ENoG showing >90% amplitude reduction suggests severe denervation 1
- Absent volitional activity on EMG indicates complete denervation 1
- Testing should be performed 3-14 days after symptom onset 1
Management Based on Lesion Type
LMN Lesions (Bell's Palsy)
Medical Management:
- Oral corticosteroids (prednisone 1-1.5 mg/kg daily) within 72 hours of symptom onset is the standard of care, achieving 94% recovery rates. 2, 1
- Antiviral monotherapy alone should not be prescribed 2
- Antiviral therapy may be added to steroids as an option 2
Eye Protection:
- Implement eye protection immediately for patients with impaired eye closure to prevent exposure keratitis or corneal abrasion. 2
- This includes artificial tears, lubricating ointment, and eye taping 2
Surgical Decompression:
- Consider middle fossa decompression only for highly selected patients with complete paralysis, >90% ENoG amplitude reduction, absent EMG activity, and surgery within 3-14 days of onset. 1
- Achieves House-Brackmann grade I/II in 91% versus 42% with steroids alone in selected patients 1
- Target is the labyrinthine segment at the meatal foramen 1
- Most Bell's palsy patients (70-94%) recover without surgery—surgical intervention is reserved for the small subset with severe electrodiagnostic findings. 1
Follow-up:
- Reassess or refer patients with: (1) new/worsening neurological findings at any point, (2) ocular symptoms developing at any point, or (3) incomplete recovery at 3 months. 2
UMN Lesions (Stroke/Central Causes)
Immediate stroke protocol management is required: 1
- Central facial pattern (forehead spared) plus limb weakness equals stroke until proven otherwise. 1
- Activate stroke team for thrombolysis/thrombectomy evaluation 1
- Admit for comprehensive stroke workup and secondary prevention 1
Tumor-Related Facial Nerve Pathology
Surgical principles for tumor management: 1
- Preserve facial nerve when preoperative function is intact AND dissection plane exists between tumor and nerve 1
- Resect involved nerve branches when preoperative facial movement is impaired OR nerve is encased/grossly involved by malignancy 1
For perineural tumor spread (most commonly trigeminal and facial nerves): 2
- MRI is preferred for detecting perineural spread with thin-section protocol 2
- CT visualizes neural foramina expansion 2
- FDG-PET/CT may be useful for localization and treatment response monitoring 2
Traumatic Facial Nerve Injury
Use electrodiagnostic testing to guide treatment decisions, with surgical decompression considered for severe denervation. 1
Special Considerations
Cranial Nerve Examination in Surgical Contexts
For patients undergoing head and neck surgery or radiotherapy, perform thorough cranial nerve examination and laryngoscopy before and after intervention. 2
- Evaluate cranial nerves VII-XII systematically 2
- Assess symmetric facial movement, hearing, swallowing, palate rise, shoulder elevation, and tongue mobility 2
- New cranial neuropathies occur in 30-33% even with observation alone 2
Distinguishing from Other Motor Neuron Disorders
In amyotrophic lateral sclerosis (ALS), facial nerve involvement is rare but UMN signs may be subtle. 6, 7 Motor cortex thickness on MRI is more sensitive than clinical examination for detecting UMN degeneration and can identify changes before signs become clinically evident. 7